HexemBio

ImmuneAGE

This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Appia Bio

This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.

ReproGo

This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.

clock.bio

This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.

MoglingBio

The company develops pharmacological therapies that inhibit Cdc42 protein activity to rejuvenate aged stem cells for patients with blood disorders and immune dysfunction.

Deciduous

This company develops medicines that activate the immune system to remove senescent cells for patients with age-related metabolic and fibrotic diseases.

Altos Labs

This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.